PB1734 Tetraspanin CD9 Regulates GPIIb-IIIa-Mediated Platelet Function: Identification of Unique Protein Interactomes J. Kotha1, X. Zhai1, M. Herr1,2, S. Hill3, L. Jennings1 1CirQuest Labs, Memphis, United States, 2University of Tennessee Health Science Center, Anatomy and Neurobiology, Memphis, United States, 3University of Tennessee Health Science Center, Biochemistry, Immunology, and Biochemistry, Memphis, United States
Background: Background. Tetraspanins are transmembrane proteins involved in cellular events such as adhesion, motility, and proliferation. CD9 (Tspan-29) is highly expressed on the platelet surface. Previously, it was determined that CD9 and the platelet integrin, GPIIb-IIIa form noncovalent complexes that are dependent upon the GPIIb-IIIa conformation state. Aims: The aim of this study was to further define how CD9 and its integrin partner, GPIIb-IIIa, regulate platelet function via common and unique protein interactomes. Methods: We characterized CD9-dependent platelet phenotypes using Fab fragments of a well-characterized anti-CD9 mAb (mFab7). Platelet adhesion and spreading were examined on matrices fibrinogen (FG), fibronectin (FN), fibrin (Fb) or Fb-FN. Platelet activation, GPIIb-IIIa -mediated aggregation response and aggregate stability (LTA) were measured after mFab7 ligation or addition of a recombinant CD9 protein fragment. Protein interactomes were characterized by immunoprecipitation (IP) by 10E5 (anti-GPIIb-IIIa) or mAb7 (n=3) followed by shotgun mass spectrometry. Results: Confocal microscopy showed that CD9 was highly localized in platelet-platelet contact regions. mFab7 pre-treatment increased platelet spreading and LTA responses to threshold levels of agonists ADP or collagen by 40% (p< 0.01) and 20% (p< 0.05), respectively. Consistent with platelet activation, fibrinogen binding, CD62p and CD63 expression were significantly increased (p< 0.01). Interactome analyses identified 24 proteins common to both CD9 and GPIIb-IIIa. Six unique protein interaction partners for CD9 included tetraspanin-9, CD63 and Rho family GTPase-activating proteins (p ≤ 0.001) whereas eight unique GPIIb-IIIa partners included cytoskeleton organization regulators (p ≤ 0.01) and complexes involved in early stage hemostasis (p ≤ 0.001). Conclusions: CD9 localizes to platelet-platelet contacts, modulates GPIIb-IIIa functional status and facilitates platelet responses to ligands upon platelet activation. Such interactions are likely controlled by co-complex members that serve as hubs for the crosstalk of different signaling events. Our findings provide new molecular insights contributing toward a better understanding of platelet signaling and function that might improve therapeutic strategies.
Main Topic: Platelets and Megakaryocytes
Category: Platelet Receptors
PB1734 Tetraspanin CD9 Regulates GPIIb-IIIa-Mediated Platelet Function: Identification of Unique Protein Interactomes J. Kotha1, X. Zhai1, M. Herr1,2, S. Hill3, L. Jennings1 1CirQuest Labs, Memphis, United States, 2University of Tennessee Health Science Center, Anatomy and Neurobiology, Memphis, United States, 3University of Tennessee Health Science Center, Biochemistry, Immunology, and Biochemistry, Memphis, United States
Background: Background. Tetraspanins are transmembrane proteins involved in cellular events such as adhesion, motility, and proliferation. CD9 (Tspan-29) is highly expressed on the platelet surface. Previously, it was determined that CD9 and the platelet integrin, GPIIb-IIIa form noncovalent complexes that are dependent upon the GPIIb-IIIa conformation state. Aims: The aim of this study was to further define how CD9 and its integrin partner, GPIIb-IIIa, regulate platelet function via common and unique protein interactomes. Methods: We characterized CD9-dependent platelet phenotypes using Fab fragments of a well-characterized anti-CD9 mAb (mFab7). Platelet adhesion and spreading were examined on matrices fibrinogen (FG), fibronectin (FN), fibrin (Fb) or Fb-FN. Platelet activation, GPIIb-IIIa -mediated aggregation response and aggregate stability (LTA) were measured after mFab7 ligation or addition of a recombinant CD9 protein fragment. Protein interactomes were characterized by immunoprecipitation (IP) by 10E5 (anti-GPIIb-IIIa) or mAb7 (n=3) followed by shotgun mass spectrometry. Results: Confocal microscopy showed that CD9 was highly localized in platelet-platelet contact regions. mFab7 pre-treatment increased platelet spreading and LTA responses to threshold levels of agonists ADP or collagen by 40% (p< 0.01) and 20% (p< 0.05), respectively. Consistent with platelet activation, fibrinogen binding, CD62p and CD63 expression were significantly increased (p< 0.01). Interactome analyses identified 24 proteins common to both CD9 and GPIIb-IIIa. Six unique protein interaction partners for CD9 included tetraspanin-9, CD63 and Rho family GTPase-activating proteins (p ≤ 0.001) whereas eight unique GPIIb-IIIa partners included cytoskeleton organization regulators (p ≤ 0.01) and complexes involved in early stage hemostasis (p ≤ 0.001). Conclusions: CD9 localizes to platelet-platelet contacts, modulates GPIIb-IIIa functional status and facilitates platelet responses to ligands upon platelet activation. Such interactions are likely controlled by co-complex members that serve as hubs for the crosstalk of different signaling events. Our findings provide new molecular insights contributing toward a better understanding of platelet signaling and function that might improve therapeutic strategies.
By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS). USER TERMS AND CONDITIONS | PRIVACY POLICY
Cookie Settings Accept Terms & all Cookies
Anonymous User Privacy Preferences
Strictly Necessary Cookies (Always Active)
MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.
Performance Cookies
Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.
Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.